Dru S. Dace

414 total citations
8 papers, 337 citations indexed

About

Dru S. Dace is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Dru S. Dace has authored 8 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Dru S. Dace's work include Immunotherapy and Immune Responses (3 papers), Immune cells in cancer (2 papers) and Ocular Oncology and Treatments (2 papers). Dru S. Dace is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Immune cells in cancer (2 papers) and Ocular Oncology and Treatments (2 papers). Dru S. Dace collaborates with scholars based in United States and Russia. Dru S. Dace's co-authors include Rajendra S. Apte, Jennifer Kelly, Aslam Khan, Peter W. Chen, Aslam A. Khan, Jérry Y. Niederkorn, Alexey G. Ryazanov, Nuran Erçal, Abdoulaye Sène and Anne H. Cross and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and American Journal Of Pathology.

In The Last Decade

Dru S. Dace

8 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dru S. Dace United States 8 128 107 100 39 38 8 337
Jennifer Kelly United States 4 153 1.2× 158 1.5× 120 1.2× 32 0.8× 54 1.4× 5 397
Xiaoting Xi China 10 37 0.3× 95 0.9× 263 2.6× 17 0.4× 25 0.7× 15 398
Hiroshi Mochimaru Japan 15 113 0.9× 251 2.3× 209 2.1× 118 3.0× 175 4.6× 25 748
Laura Tudisco Italy 13 47 0.4× 32 0.3× 134 1.3× 42 1.1× 35 0.9× 18 331
Siyuan He China 8 84 0.7× 52 0.5× 205 2.0× 51 1.3× 14 0.4× 18 401
Jeong A Choi South Korea 10 18 0.1× 146 1.4× 183 1.8× 19 0.5× 37 1.0× 11 409
Jin Yao China 8 15 0.1× 91 0.9× 119 1.2× 58 1.5× 49 1.3× 17 310
Elena Alcalde‐Estévez Spain 11 66 0.5× 59 0.6× 129 1.3× 6 0.2× 17 0.4× 17 348
Sandeep Artham United States 13 65 0.5× 29 0.3× 211 2.1× 63 1.6× 7 0.2× 23 421

Countries citing papers authored by Dru S. Dace

Since Specialization
Citations

This map shows the geographic impact of Dru S. Dace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dru S. Dace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dru S. Dace more than expected).

Fields of papers citing papers by Dru S. Dace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dru S. Dace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dru S. Dace. The network helps show where Dru S. Dace may publish in the future.

Co-authorship network of co-authors of Dru S. Dace

This figure shows the co-authorship network connecting the top 25 collaborators of Dru S. Dace. A scholar is included among the top collaborators of Dru S. Dace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dru S. Dace. Dru S. Dace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Schimel, Andrew M., Linu Abraham, Douglas N. Cox, et al.. (2011). N-Acetylcysteine Amide (NACA) Prevents Retinal Degeneration by Up-Regulating Reduced Glutathione Production and Reversing Lipid Peroxidation. American Journal Of Pathology. 178(5). 2032–2043. 50 indexed citations
2.
Khan, Aslam A., Dru S. Dace, Alexey G. Ryazanov, Jennifer Kelly, & Rajendra S. Apte. (2010). Resveratrol Regulates Pathologic Angiogenesis by a Eukaryotic Elongation Factor-2 Kinase-Regulated Pathway. American Journal Of Pathology. 177(1). 481–492. 43 indexed citations
3.
Dace, Dru S., Aslam A. Khan, Jennifer Stark, et al.. (2009). Interleukin-10 Overexpression Promotes Fas-Ligand-Dependent Chronic Macrophage-Mediated Demyelinating Polyneuropathy. PLoS ONE. 4(9). e7121–e7121. 35 indexed citations
4.
Dace, Dru S. & Rajendra S. Apte. (2008). Effect of Senescence on Macrophage Polarization and Angiogenesis. Rejuvenation Research. 11(1). 177–185. 43 indexed citations
5.
Dace, Dru S., Aslam Khan, Jennifer Kelly, & Rajendra S. Apte. (2008). Interleukin-10 Promotes Pathological Angiogenesis by Regulating Macrophage Response to Hypoxia during Development. PLoS ONE. 3(10). e3381–e3381. 121 indexed citations
6.
Dace, Dru S., Peter W. Chen, & Jérry Y. Niederkorn. (2007). CD4+ T‐cell‐dependent tumour rejection in an immune‐privileged environment requires macrophages. Immunology. 123(3). 367–377. 22 indexed citations
7.
Dace, Dru S., Peter W. Chen, & Jérry Y. Niederkorn. (2007). CD8+ T Cells Circumvent Immune Privilege in the Eye and Mediate Intraocular Tumor Rejection by a TNF-α-Dependent Mechanism. The Journal of Immunology. 178(10). 6115–6122. 14 indexed citations
8.
Dace, Dru S., Peter W. Chen, Hassan Alizadeh, & Jérry Y. Niederkorn. (2006). Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-γ-dependent manner. Journal of Leukocyte Biology. 81(2). 421–429. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026